Bill Williams
@BillTXCeutics
Followers
378
Following
3K
Media
69
Statuses
2K
Big news: @MDPIpharma announced the winners of the Pharmaceutics 2023 Best Paper Award!🏆Congrats to Miguel O. Jara and Zachary Warnken for their paper on gaining a better understanding of the dissolution process of niclosamide amorphous solid dispersions: https://t.co/wERHYkpshR
1
3
5
"That's what AAPS provides, a community of experts to help move the science forward," explains @BillTXCeutics. The Editor-in-Chief of AAPS' @pharmscitech, Bill Williams, explains the difference between good science and bad science during #EthicsAwarenessMonth. #ethics
0
2
3
We’re excited to announce that Dr. Bill Williams and his team at @UTexasPharmacy’s publication on the use of Thin Film Freezing to improve delivery of biologics was selected as a 2023 featured article in the KONA Powder and Particle Journal. Take a look: https://t.co/WFmt7Vzkgz
1
3
4
AAPS and its members continually contribute credible research to the body of science. AAPS recognizes National Ethics Awareness Month and the importance of ethically conducted, accessible research in pharmaceutical science. #EthicsAwarenessMonth #ethics
https://t.co/Aj465AXp0b
0
1
3
.@PHLBizJournal featured highlights from our recent business update call with new CEO Harlan Weisman, M.D. We look forward to further progressing our internal pipeline and developing high-value products using #ThinFilmFreezing technology. Read more here: https://t.co/CMrZuGMoMC
0
1
2
What makes #ThinFilmFreezing different from other competing technologies? Our technology creates uniform particles that are suitable for dry powder inhalers, while other methods do not. Learn more about our technology here: https://t.co/weByvpnkZo
0
2
5
Featured in our "Inhaled Drug Delivery of Biologics for Therapeutic and Vaccination" collection, the article reviews previous studies to support the feasibility of developing pMDI and DPI versions of The LNP-mRNA intramuscular #vaccines from #moderna (mR… https://t.co/KPiu9rVWYs
0
1
3
Read the featured article from the Novel Advances in 3-D Printing Technology in Drug Delivery by Bhupendra Raj Giri and Mo Maniruzzaman. The article titled: "Fabrication of Sustained-Release Dosages Using Powder-Based Three-Dimensional (3D) Printing Techn… https://t.co/abZkp5h08v
linkedin.com
Read the featured article from the Novel Advances in 3-D Printing Technology in Drug Delivery collection by Bhupendra Raj Giri and Mo Maniruzzaman. The article titled: "Fabrication of Sustained-Rel...
0
1
3
Don Owens, our Director, Product Dev., recently shared his insights on building new solutions for 2023 within the biopharma manufacturing and supply chain with @BenMComer for @LifeSciLeader1 Read the full article here: https://t.co/CB9AEthvXM
0
1
2
#ICYMI: Our VP Product Dev. & Manufacturing, John Koleng, shared his views on the ongoing growth and evolution of the #CDMO industry with @Louis_Garguilo for @LifeSciLeader1. Read the article here: https://t.co/kA2nr59PSF
0
2
3
Dr. Bradley Gardiner of the Alfred Hospital spoke with @Contagion_Live about treating patients with TFF's inhaled #voriconazole therapy in a compassionate use setting. Learn more here:
contagionlive.com
Two patients at a hospital in Australia were administered Thin Film Freezing Voriconazole Inhalation Powder (TFF VORI), which showed treatment efficacy for both patients.
0
3
5
Check out our “Resources” page to learn more about our scientific highlights and milestones, including published research on our #ThinFilmFreezing technology. View the page here: https://t.co/emPsGn3G85
1
1
2
#MDPIPharmaceutics "Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution" by Miguel O. Jara et al. Full paper at： https://t.co/heAJou50ZI
0
1
2
We’re excited to be a part of the recent @statnews report from @JonathanWosen on the future of #mRNA. Our VP, Product Dev. & Manufacturing, Dr. John Koleng, and SAB member Dr. Drew Weissman contributed as sources for the project. Purchase the report here: https://t.co/uqklSF98Q3
1
3
6
#DYK that three-dimensional #bioprinting technology has been predicted to be a game-changing breakthrough in the pharmaceutical industry? Discover the latest in #3Dprinting research in one of the most downloaded @pharmscitech articles of the year: https://t.co/5V3qWmxKwu
link.springer.com
AAPS PharmSciTech - The gemstone of 3-dimensional (3D) printing shines up from the pyramid of additive manufacturing. Three-dimensional bioprinting technology has been predicted to be a...
0
1
1
TFF’s Director of Product Development, Don Owens, Ph.D., and Manager of Process Engineering, Kayla Hannon, weighed in on the recent acceleration of #DrugDevelopment in this @BioPharmIntl article. Read more here: https://t.co/8r9CDNj0d7
0
2
3
Way to go Vineet!!
Congratulations to the winners of this year's Three Minute Thesis (3MT) competition! Atreya Dey (center) won 1st place, Ana Guadalupe Vielma (right) was announced as runner-up and Vineet Kulkarni (left) was chosen as the people's choice winner.
0
0
2
We are working with @aptar to explore & develop intranasal delivery of dry powder vaccines & therapeutics using our #ThinFilmFreezing technology. We worked with @UTexasPharmacy to develop a pre-print publication with Aptar about the technology. More here: https://t.co/cMzOOArMnP
1
2
6
Leaders from the American Association of Pharmaceutical Scientists (AAPS), including Texas Pharmacy's Dr. Robert O. (Bill) Williams III, discuss the “infodemic” & AAPS’ role in evaluating & bringing attention to credible science on a Nov. 5 epi of "Advancements with Ted Danson."
1
3
7
